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Abstract 
Epilepsy is a prevalent neurological disorder with a high frequency of drug resistance. While significant 
advancements have been made in drug delivery systems to overcome anti-epileptic drug resistance, 
efficacies of materials in biological systems have been poorly studied. The purpose of the study was to 
evaluate the anti-epileptic effects of injectable poly(epsiloncaprolactone) (PCL) microspheres for 
controlled release of an anticonvulsant, phenytoin (PHT), in an animal model of epilepsy. Methods: PHT-
PCL and Blank-PCL microspheres formulated using an oil-in-water (O/W) emulsion solvent evaporation 
method were evaluated for particle size, encapsulation efficiency, surface morphology and in-vitro drug 
release profile. Microspheres with the most suitable morphology and release characteristics were 
subsequently injected into the hippocampus of a rat tetanus toxin model of temporal lobe epilepsy. 
Electrocorticography (ECoG)from the cerebral cortex were recorded for all animals. The number of 
seizure events, severity of seizures, and seizure duration were then compared between the two treatment 
groups. Results: We have shown that small injections of drug-loaded microspheres are biologically 
tolerated and released PHT can control seizures for the expected period of time that is in accord with in-
vitro release data. Conclusion: The study demonstrated the feasibility of polymer-based delivery systems 
in controlling focal seizures. 
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Abstract. 
Purpose: Epilepsy is a prevalent neurological disorder with a high frequency of drug resistance. While significant advance-
ments have been made in drug delivery systems to overcome anti-epileptic drug resistance, efficacies of materials in biological 
systems have been poorly studied. The purpose of the study was to evaluate the anti-epileptic effects of injectable poly(epsilon-
caprolactone) (PCL) microspheres for controlled release of an anticonvulsant, phenytoin (PHT), in an animal model of epilepsy. 
Methods: PHT-PCL and Blank-PCLmicrospheres formulated using an oil-in-water(O/W) emulsion solvent evaporation method 
were evaluated for particle size, encapsulation efficiency, surface morphology and in-vitro drug release profile. Microspheres 
with the most suitable morphology and release characteristics were subsequently injected into the hippocampus of a rat tetanus 
toxin model of temporal lobe epilepsy. Electrocorticography (ECoG)from the cerebral cortex were recorded for all animals. The 
number of seizure events, severity of seizures, and seizure duration were then compared between the two treatment groups. 
Results: We have shown that small injections of drug-loaded microspheres are biologically tolerated and released PHT can 
control seizures for the expected period of time that is in accord with in-vitro release data. 
Conclusion: The study demonstrated the feasibility of polymer-based delivery systems in controlling focal seizures. 
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1. Introduction 
Advances in biomaterial science over the past 
decades have resulted in a dramatic expansion in the 
*Corresponding author: Dr. Jonathan L. Jiang, St Vincent's 
Department of Medicine, University of Melbourne, Fitzroy, VIC 
3065, Australia. Tel.: +61 3 9288 3517: Fax: +61 3 9288 3350: 
E-mail: jonathan.jiang@ unimelb.edu.au. 
use of polymer-based drug delivery systems (Halli-
day & Cook, 2009; Halliday et al., 2012). In addition 
to applications in management of cancers and dia-
betes (Gallia et al., 2005; Traitel et al., 2000), multiple 
animal studies have demonstrated successes in using 
polymer based implants to treat neurological disorders 
including Parkinson's disease, Huntington's disease 
and Alzheimer's disease (Halliday & Cook, 2009). 
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